Adult Vaccine Market to reach US$ 22 Billion by 2024

1
Adult Vaccine Market
Category Vaccines Market Research Report
2
Adult Vaccine Market Analyst View Adult
Vaccine Market is projected to reach US 22
Billion by the year 2024. Get Free
Customization in this Report Research Report
Title Adult Vaccine Market, Global Analysis By
Disease Influenza, Cervical Cancer, Zoster
(Shingles), MMR (Measles, Mumps, and Rubella),
Pneumonia, Meningitis, Hepatitis, Tap
(Diphtheria, Tetanus, Pertussis), Varicella and
Travel Miscellaneous Vaccine, Companies
(GlaxoSmithKline, Merck, Sanofi, Pfizer,
Others) Access Full Research  https//www.renub.
com/adult-vaccines-market-company-adult-vaccines-s
ales-country-adult-vaccines-worldwide-analysis-19-
p.php

3
Adult Vaccine Market is projected to reach US 22
Billion by 2024.
As per Renub Research analysis Adult Vaccine
Market is projected to reach US 22 Billion by
the year 2024. Vaccination can help prevent
certain diseases in all the people. Nearly all
countries across the globe have introduced a
well-organized National immunization Programs in
their vaccination schedule to overcome the
outbreak of vaccine-preventable diseases. Several
organizations such as Global Immunization Vision
and Strategy (GIVS), WHOs Global Vaccine Action
Plan, The GAVI Alliance are putting their best to
reduce the occurrence of vaccine-preventable
diseases around the world which certainly is
driving the adult vaccine market
sturdily. Rising prevalence of diseases, growing
awareness among the people regarding
vaccine-preventable diseases, increasing
investments by companies to develop new vaccines
and increasing governments and other healthcare
authorities (Bill Melinda Gates Foundation)
funding for promoting immunization programs as
well as for the developments distribution of
the vaccines are some other key factors which are
anticipated to augment the growth of global adult
vaccine during the forecast period.   Request a
free sample copy of the report  https//www.renub
.com/contactus.php

4
Adult Vaccine Market is projected to reach US 22
Billion by 2024.
Renub Research report titled Adult Vaccine
Market, Global Analysis By Disease Influenza,
Cervical Cancer, Zoster (Shingles), MMR (Measles,
Mumps, and Rubella), Pneumonia, Meningitis,
Hepatitis, Tap (Diphtheria, Tetanus, Pertussis),
Varicella and Travel Miscellaneous Vaccine,
Companies (GlaxoSmithKline, Merck, Sanofi,
Pfizer, Others) provides a complete analysis
of Global Adults Vaccine Market. By Disease -
Pneumococcal Vaccine is likely to grow at
noteworthy rate over the coming years The report
studies the market of the following vaccine
Influenza, Cervical Cancer, Zoster (Shingles),
MMR (Measles, Mumps, and Rubella), Pneumonia,
Meningitis, Hepatitis, Tap (Diphtheria, Tetanus,
Pertussis), Varicella, and Travel Miscellaneous
Vaccine. Pneumococcal and Hepatitis together hold
the significant market share in global adult
vaccine market and is expected to continue so in
the forecast period.   By End User Global
Adults Vaccine Market The report studies the
market by end user as Adults. Around the world,
thousands of adults become seriously ill, get
hospitalized and even die because of diseases
that vaccines can help prevent. By getting
vaccinated, one can help protect themselves from
much of this needless suffering.

5
Adult Vaccine Market is projected to reach US 22
Billion by 2024.

6
Pediatric Vaccine Market is projected to exceed
US 48 Billion by 2024.
Almost 350 Million Adults get vaccinated by
2024 Due to the increasing prevalence of diseases
and growing awareness regarding the
vaccine-preventable diseases, it is estimated
that by the year 2024, nearly 350 million adults
get vaccinated in order to protect themselves
from diseases. Some of the vaccines which hold
considerable share in terms of adult vaccination
include Influenza, Hepatitis, HPV and Pneumonia
vaccine.   Company Analysis GlaxoSmithKline,
Merck, Sanofi, and Pfizer are some of the top
companies that deal efficiently in vaccine
business globally. These companies have been
studied thoroughly in the report. Regional -
Immunization Profile The report also studies the
Immunization profile around the world By Disease
- Measles, Mumps, Rubella, Japanese encephalitis,
Tetanus, Pertussis, Yellow Fever. While By
Regions, it studies Americas (AMR), Europe (EUR),
Africa (AFR), Eastern Mediterranean (EMR),
South-East Asia (SEAR), Western Pacific (WPR) and
Global.

7
Adult Vaccine Market is projected to reach US 22
Billion by 2024.
Client can Purchase this Report in Sections from
below link   Access full Research https//www.re
nub.com/adult-vaccines-market-company-adult-vaccin
es-sales-country-adult-vaccines-worldwide-analysis
-19-p.php   Global Adults Vaccine Market has
been extensively studied from 3 major
points 1.    Adult Vaccines (Disease wise)
Market Forecast2.    Number of Vaccinated
Adults (Disease wise) Forecast3.    Doses of
Vaccines Administered in Adults(Disease wise)
Forecast  By Disease     Influenza   
 Cervical Cancer    Zoster (Shingles)   
 MMR     Pneumonia     Meningitis  
 Hepatitis     Tap (Diphtheria, Tetanus,
Pertussis)    Varicella     Travel
Miscellaneous Vaccine

8
Table of Contents for Adult Vaccine Market
Key Companies Covered in the Report   
 GlaxoSmithKline    Merck    Sanofi  
 Pfizer Key Topics Covered 1.    Research
Findings 2.    Adult Vaccines Market (2011
2024) 3.    Market Numbers Share - Adult
Vaccines 3.1    Adult Vaccine Market Share 3.2  
 Adult Vaccinated Population Share 3.3    Adult
Doses of Vaccines Administered Share 3.4  
 Vaccine Companies Market Share 4.    Adult
Vaccinated Numbers 5.    Adult Doses of Vaccines
Administered

9
Table of Contents for Adult Vaccine Market
6.    Disease wise Adult Vaccines Market (2011
2024) 6.1    Influenza 6.2    Cervical
Cancer (HPV) 6.3    Zoster (Shingles) 6.4  
 MMR 6.5    Pneumococcal 6.6  
 Meningococcal 6.7    Hepatitis 6.8  
 TdaP 6.9    Travel and Miscellaneous 6.10  
 Varicella 7.    Disease wise Numbers of
Vaccinated Adults (2011 2024) 7.1  
 Influenza 7.2    Cervical Cancer (HPV) 7.3  
 Zoster (Shingles) 7.4    MMR 7.5  
 Pneumococcal 7.6    Meningococcal 7.7  
 Hepatitis 7.8    TdaP 7.9    Varicella 8.  
 Disease wise Doses of Vaccines Administered in
Adults (2011 2024) 8.1    Influenza 8.2  
 Cervical Cancer (HPV) 8.3    Zoster
(Shingles) 8.4    MMR 8.5    Pneumococcal 8.6 
   Meningococcal 8.7    Hepatitis 8.8  
 TdaP 8.9    Varicella

10
Table of Contents for Adult Vaccine Market
9.    Disease wise - Immunization Profile 9.1  
 Immunization Coverage () in Infants 9.2  
 Global Immunization Profile 9.3    By Geographic
Region Immunization Profile 10.    Vaccines Key
Players Sales (2011 2024) 10.1  
 GlaxoSmithKline, plc.s Vaccines Sales 10.2  
 Merck Co. Vaccines Sales 10.3    Sanofi
Pasteurs Vaccines Sales 10.4    Pfizer, Inc.s
Vaccines Sales 10.5    Global Other Companies
Vaccines Sales 11.    Vaccines Products and
Pipeline 11.1    GSK Vaccine Product
Pipeline 11.2    Merck Vaccine Product
Pipeline 11.3    Sanofi Vaccine Product
Pipeline 11.4    Pfizer Vaccine Product
Pipeline 12.    Top Mergers and Acquisitions in
the Vaccine Industry 13.    Vaccines and
Regulators Interventions 13.1    Making and
Meeting Standards of Quality and Safety 13.2  
 Vaccine Funding

11
Table of Contents for Adult Vaccine Market
14.    Vaccine Market Drivers 14.1    Inclusion
in National Immunization Schedule 14.2    Growing
Immunization Coverage for HPV Vaccines 14.3  
 Increase in Prevalence of Infectious
Diseases 14.4    Global Immunization Vision and
Strategy (GIVS) 14.5    GAVI Model Fuelling
Vaccine Manufacturers 14.6    Increasing Vaccine
Availability in United States 14.7    The Vaccine
Safety Data link Project 14.8    The Vaccine
Injury Compensation Program 14.9    Transforming
of Vaccine Technologies 14.10    Global Vaccine
Action Plan by WHO (2011 - 2020) 14.11  
 Continuous Focus on Effective Communication
Strategies 15.    Vaccines Market
Challenges 15.1    Hurdles to Optimal use of
Licensed Vaccines 15.2    Complexity of Vaccine
Development Approval System Thwarts Product
Development 15.3    Shortening the Timeline for
Vaccine Development 15.4    Refusal/Resistance to
Vaccination 15.5    Vaccine Shortages and
Delays 15.6    Obstacles in Vaccine Research
Development 15.7    Barriers to New Entrants in
the Vaccines Market

12
Get Free Customization in this Report

Vaccines Market Reports https//www.renub.com/va
ccines-12-c.php
Renub Research - North America Rajat Gupta 225 Kristie Ln, Roswell Georgia 30076, United States Tel [phone] Email info_at_renub.com www.renub.com Renub Research - Asia Ankit Mishra C 86, Sector 10 Noida 201301, India Tel [phone] Email info_at_renub.com www.renub.com